• Echoiq Ltd received $762,662.01 in R&D tax incentives
• The claim covers the financial year ended 30 June 2025
• The refund recognizes expenditure on AI innovation and medical technology
• Incentive is part of the Australian Government's R&D Tax Incentive Scheme

Echo IQ Limited (ASX: EIQ), an AI and medical technology company, has confirmed the receipt of $762,662.01 under the Australian Government's Research and Development (R&D) Tax Incentive Scheme. This refund covers the financial year ended 30 June 2025 and recognizes the company's expenditure on R&D activities related to artificial intelligence innovation and the development of decision-support solutions for detecting structural heart disease. The R&D Tax Incentive Scheme is designed to support eligible companies through refundable and non-refundable tax offsets, with companies having a turnover under $20 million eligible for a refundable offset of up to 43.5% of eligible R&D expenditure.

Echoiq Ltd anticipates continued investment in R&D to further its AI and medical technology innovations.